NRX Pharmaceuticals Inc (NRXP)
3.51
-0.01
(-0.28%)
USD |
NASDAQ |
May 17, 16:00
3.51
0.00 (0.00%)
After-Hours: 20:00
NRX Pharmaceuticals Total Assets (Quarterly): 3.788M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.788M |
| December 31, 2023 | 7.315M |
| September 30, 2023 | 13.11M |
| June 30, 2023 | 19.81M |
| March 31, 2023 | 21.78M |
| December 31, 2022 | 25.82M |
| September 30, 2022 | 24.82M |
| Date | Value |
|---|---|
| June 30, 2022 | 32.43M |
| March 31, 2022 | 43.60M |
| December 31, 2021 | 32.73M |
| September 30, 2021 | 45.25M |
| June 30, 2021 | 18.55M |
| December 31, 2020 | 2.941M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.941M
Minimum
Dec 2020
45.25M
Maximum
Sep 2021
22.46M
Average
21.78M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 8.805M |
| Achieve Life Sciences Inc | 70.03M |
| EyePoint Pharmaceuticals Inc | 329.25M |
| Nanoviricides Inc | 11.46M |
| GlycoMimetics Inc | 34.20M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.86M |
| Shareholders Equity (Quarterly) | -15.07M |